🩹 SCORTEN (SJS/TEN Mortality)
UseWhen to use: admission day 1 (and day 3) severity triage for epidermal necrolysis.
Strata0–1 ~3.2%, 2 ~12.1%, 3 ~35.3%, 4 ~58.3%, ≥5 ≥90% published mortality.
LimitsWhen not to use: non-SJS/TEN rashes. · Pitfall: delayed BSA reassessment. · Not a sole burn-bed mandate.
SourceSCORTEN (Bastuji-Garin et al., J Invest Dermatol) SJS/TEN mortality
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Seven equal points.
When to use
When to use: admission day 1 (and day 3) severity triage for epidermal necrolysis.
How it works
Sum of 7 binary factors (age ≥40, malignancy, HR ≥120, BSA ≥10%, urea >10, glucose >14, HCO₃⁻ <20).
Key points
- Seven equal points.
- Recalculate day 3.
- Next: burn/derm ICU pathway.
References
- SCORTEN (Bastuji-Garin et al., J Invest Dermatol) SJS/TEN mortality
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Age ≥40 years | No (0) |
|---|---|
| Presence of malignancy | No (0) |
| Heart rate ≥120 bpm | No (0) |
| Detached / compromised BSA ≥10% | No (0) |
| Serum urea >10 mmol/L (BUN >28 mg/dL) | No (0) |
| Serum glucose >14 mmol/L (>250 mg/dL) | No (0) |
| Serum bicarbonate <20 mmol/L | No (0) |
→SCORTEN0/7
- Predicted mortality：3.2%
- Band：0–1 — published mortality ~3.2%
| Age ≥40 years | Yes (+1) |
|---|---|
| Presence of malignancy | Yes (+1) |
| Heart rate ≥120 bpm | Yes (+1) |
| Detached / compromised BSA ≥10% | Yes (+1) |
| Serum urea >10 mmol/L (BUN >28 mg/dL) | Yes (+1) |
| Serum glucose >14 mmol/L (>250 mg/dL) | Yes (+1) |
| Serum bicarbonate <20 mmol/L | Yes (+1) |
→SCORTEN7/7
- Predicted mortality：90.0%
- Band：≥5 — ≥90%
Verification & sources · governance
FAQ
Frequently asked questions
- Does SCORTEN (SJS/TEN Mortality) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is SCORTEN (SJS/TEN Mortality) calculated in practice? Can you show a worked example?
- Inputs: Age ≥40 years No (0), Presence of malignancy No (0), Heart rate ≥120 bpm No (0), Detached / compromised BSA ≥10% No (0), Serum urea >10 mmol/L (BUN >28 mg/dL) No (0), Serum glucose >14 mmol/L (>250 mg/dL) No (0), Serum bicarbonate <20 mmol/L No (0) → Result: SCORTEN 0 /7（Predicted mortality: 3.2%, Band: 0–1 — published mortality ~3.2%） Inputs: Age ≥40 years Yes (+1), Presence of malignancy Yes (+1), Heart rate ≥120 bpm Yes (+1), Detached / compromised BSA ≥10% Yes (+1), Serum urea >10 mmol/L (BUN >28 mg/dL) Yes (+1), Serum glucose >14 mmol/L (>250 mg/dL) Yes (+1), Serum bicarbonate <20 mmol/L Yes (+1) → Result: SCORTEN 7 /7（Predicted mortality: 90.0%, Band: ≥5 — ≥90%）